Remove Biotech Remove Capital Remove Research
article thumbnail

Top 10 countries attracting international tech talent

CIO

Capital Berlin, for one, has become a popular city for business relocation and international investments, with companies such as Volkswagen, Pfizer, and SAP having set up innovation labs there. As the capital city of the United States, Washington, D.C., in the San Francisco Bay Area.

Startups 516
article thumbnail

Slow Start to Venture Capital Funding in 2024

Alpha Sense BI

The venture capital landscape continues to test the discipline and diligence of investors and startups alike. Like many other asset classes, venture capital continues to be impacted by lingering macroeconomic factors affecting funding and liquidity prospects. Interest rates are high.

Capital 69
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Top IPOs to Watch in 2025 | APAC Region

Alpha Sense BI

The firm has been publicly traded in Shanghai since 2000, and this would be Hengruis first major capital raise in over two decades. The IPO proceeds will go toward new production and research facilities worldwide, as well as expanding and upgrading existing factories in China.

article thumbnail

Key Takeaways from J.P. Morgan’s 41st Annual Healthcare Conference?

Alpha Sense BI

Attracting industry leaders, emerging fast-growth companies, and technology creators from around the world, life science corporations share their latest advances, leading research, and best practices — as well as their intentions to scale their digital health solutions — to the masses in hopes of securing capital.

Biotech 96
article thumbnail

Venture Capital Trends and Outlook for 2024

Alpha Sense BI

Heading into the second half of 2024, venture capital investors remain cautious as they acknowledge persistent challenging dynamics in the landscape. While dry powder reserves have reached record highs, investors are wary about deploying capital with certain recent macroeconomic factors still fresh in mind.

Capital 52
article thumbnail

Vaccine Development: What to Expect in 2023

Alpha Sense BI

Moderna and BioTech, the pharmaceuticals companies behind the Moderna vaccines for the COVID-19 virus, just announced a new treatment this past December that would greatly reduce the chances of death from melanoma — stirring up substantial interest in investors to funnel capital. a potential cure for skin cancer.

Biotech 96
article thumbnail

M&A Trends and Outlook for 2023

Alpha Sense BI

Around the world, investors are favoring companies that have proven their profitability and that can demonstrate how they have successfully utilized their capital. Many pharma companies with expiring patents are on the hunt to acquire biotech companies to address gaps in drug pipelines.

Biotech 97